Gastric Cancer Diagnostics Market size was valued at US$ 3.5 Bn in 2024 and is projected to reach US$ 6.9 Bn by 2035, growing ...

As new technology capable of detecting dozens of early-stage cancer types with a single blood test hits the market, support ...

The U.S. Food and Drug Administration has approved Imfinzi (durvalumab) in combination with standard-of-care FLOT ...

As the first immunotherapy option in this setting, the approval sets a new standard for resectable early-stage gastric and gastroesophageal junction (GEJ) cancers.

Testing for changes in breast cancer genes that can be inherited and greatly increase a person’s risk of getting certain ...

The FDA has approved durvalumab plus fluorouracil, leucovorin, oxaliplatin and docetaxel chemotherapy as neoadjuvant and ...

At 34 years old, I was in the emergency room hearing the words "stage 4 colorectal cancer." It had already spread to my liver. While I'd been feeling fatigue and battling stomach issues for a while, ...

However, if doctors think the cancer may have spread to the lymph nodes, they usually recommend a much more serious surgery ...

Novel blood tests as well as artificial intelligence are part of an accelerating effort to catch cancer before it kills.

The FDA has approved durvalumab (Imfinzi) plus fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for the treatment ...

Cancer continues to be one of the world's top causes of death, partly because of delayed discovery of the disease. But according to a recently released study, a simple blood test may be able to ...